LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.32 Cr | ₹1.90 Cr | ₹0.68 Cr | ₹0.58 Cr | ₹0.46 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LACTOSE (INDIA) ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹2.32 Cr |
| Mar2024 | ₹1.90 Cr |
| Mar2023 | ₹0.68 Cr |
| Mar2022 | ₹0.58 Cr |
| Mar2021 | ₹0.46 Cr |
How is Deferred Tax Assets / Liabilities of LACTOSE (INDIA) Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.32 Cr | 22.20 | |
| Mar2024 | ₹1.90 Cr | 179.15 | |
| Mar2023 | ₹0.68 Cr | 17.41 | |
| Mar2022 | ₹0.58 Cr | 26.64 | |
| Mar2021 | ₹0.46 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹144.2 Cr | -5.7% | -4% | 14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -5.7% |
-4% |
14.8% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses